But their work underpins everything the production increase needs. Engineering supports production, deliveries, and the ...

Taiwan Semiconductor is in a unique place in the AI arms race. Companies like AMD and Nvidia don't build any computing units; ...

Moderna could be on the verge of a breakthrough, but the biotech's MRNA cancer vaccine catalyst is overly priced in.

Eli Lilly is currently leading the GLP-1 market, but Amylyx is seeing strong results from its GLP-1 drug candidate.

Target fell out of favor with consumers, but it has started to get back on track, and investors have taken notice.

Friday's double-digit pop celebrated a quarter in which three of four brands shrank or stalled. The one that didn't is ...

Spousal benefits max out at 50% of the amount your spouse is entitled to at full retirement age. If you delay a spousal ...

The global shortage of AI chips and components is giving Nvidia an unprecedented ability to dictate prices, which is also a ...

In the earliest stages of the AI boom, this growth resulted in stock price gains, with the shares climbing 800% over the past ...

Micron is looking beyond today's AI boom. Its latest investments reveal where it sees future demand emerging, but one major ...

D-Wave is moving from experiments to live enterprise workloads, but the valuation leaves little room for error. See what ...

SpaceX is no longer just a futuristic story. It's already a large and rapidly growing business. SpaceX generated $7.8 billion of revenue in the second quarter, up 92% from a year earlier. Adjusted ...